Clinical Trial Update: LEAC-102 for Advanced Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for LEAC-102 in advanced colorectal cancer spanning Phase 1 and Phase 2, with current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• LEAC-102

Snippet

Sponsor: Taiwan Leader Biotech Corp. | Conditions: Advanced Colorectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN